Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CINGW CINGULATE INC C/WTS 03/12/2026 (TO PUR COM)

Watchlist
0.2000.0000.00%
Trading Session  01/31 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.200
Volume
0.00
Market Cap
0
P/E(TTM)
0.00
52wk High
0.550
Shares
0
P/E(Static)
0.00
52wk Low
0.149
Float Cap
0
Bid/Ask %
6.25%
Historical High
1.080
Shs Float
0
Volume Ratio
0.00
Historical Low
0.149
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Float Cap
0
Bid/Ask %
6.25%
Historical High
1.080
Shs Float
0
Volume Ratio
0.00
Historical Low
0.149
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.
CEO: Dr. Shane J. Schaffer, Pharm.D.
Market: NASDAQ
Listing Date: 12/08/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist